Skip to main content
Article
Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes.
Annals of Surgery (2002)
  • Donald L. Morton, John Wayne Cancer Institute
  • Eddy C. Hsueh, John Wayne Cancer Institute
  • Richard Essner, John Wayne Cancer Institute
  • Leland J. Foshag, John Wayne Cancer Institute
  • Steven J. O’Day, John Wayne Cancer Institute
  • Anton Bilchik, John Wayne Cancer Institute
  • Rishab K. Gupta, John Wayne Cancer Institute
  • Dave S. B. Hoon, John Wayne Cancer Institute
  • Mepur Ravindranath, John Wayne Cancer Institute
  • J. Anne Nizze, John Wayne Cancer Institute
  • Guy Gammon, John Wayne Cancer Institute
  • Leslie A. Wanek, John Wayne Cancer Institute
  • He-jing Wang, John Wayne Cancer Institute
  • Robert M. Elashoff, John Wayne Cancer Institute
Publication Date
October 1, 2002
DOI
10.1097/00000658-200210000-00006
Citation Information
Donald L. Morton, Eddy C. Hsueh, Richard Essner, Leland J. Foshag, et al.. "Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes." Annals of Surgery Vol. 236 Iss. 4 (2002) p. 438 - 449
Available at: http://works.bepress.com/antonj-bilchik/178/